Aila Gareayaghi | Post-traumatic Stress Disorder | Best Researcher Award

Posted on by Cognitive Scientist Awards

Dr. Aila Gareayaghi | Post-traumatic Stress Disorder | Best Researcher Award

Dr. Aila Gareayaghi is a committed psychiatrist based in Kocaeli, Türkiye, with a deep passion for trauma-focused therapy, online psychotherapy, and mood and anxiety disorders. She holds the position of Lecturer and Psychiatrist at Kocaeli University and serves as Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye. Dr. Gareayaghi’s extensive clinical and academic work includes innovative research on telepsychiatry, particularly in post-disaster mental health following Türkiye’s 2023 Kahramanmaraş Earthquakes. Her international experience includes a clerkship at Johns Hopkins University, Maryland. Beyond her clinical practice, she is active in research, conference presentations, and has authored multiple peer-reviewed publications addressing PTSD, sexual dysfunction, and transphobia in healthcare. Dr. Gareayaghi is multilingual, speaks advanced English and elementary French, and is a passionate advocate for volunteerism, animal welfare, and nature conservation, integrating her holistic outlook into her psychiatric practice.

Profile

🎓 Education

Dr. Aila Gareayaghi began her academic journey with a High School Diploma from Matthew McNair Secondary School in Vancouver, Canada (2012). She earned her Doctor of Medicine (M.D.) from Bezmialem Vakıf University, Istanbul, Türkiye (2012-2018), where she built a strong foundation in medical sciences. During her medical training, she completed a prestigious clerkship in Gastroenterology at Johns Hopkins University, USA (2018), gaining international exposure to advanced clinical practices. Pursuing her passion for mental health, she specialized in Psychiatry at Kocaeli University, Türkiye (2020-2024). Under the mentorship of Prof. Dr. Elif Tatlıdil, she completed her thesis on “Telepsychiatry Services During the February 6 Earthquakes and PTSD Prevalence Six Months Later.” Additionally, Dr. Gareayaghi continuously expanded her expertise through numerous certifications in psychotherapy, cognitive behavioral therapy, dynamic psychotherapy, EMDR, and traditional Chinese medicine, emphasizing her dedication to comprehensive psychiatric care.

🧪 Experience

Dr. Gareayaghi’s professional experience reflects a blend of clinical practice, teaching, and research. She currently serves as Lecturer and Psychiatrist at the Department of Psychiatry, Kocaeli University (2024–Present), where she actively treats patients, mentors students, and conducts impactful research. As Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye, she plays a leadership role in advancing psychiatric practice and policy at the regional level. Her experience extends internationally, having completed a clinical clerkship in Gastroenterology at Johns Hopkins University, USA. Dr. Gareayaghi has presented her research extensively at national and international psychiatric congresses, covering topics from disaster psychiatry to psychosis and caregiver support. Her work demonstrates strong expertise in trauma therapy, online psychotherapy, and managing complex psychiatric conditions. She is also a prolific contributor to academic literature, authoring multiple peer-reviewed articles and book chapters addressing psychiatric emergencies and psychological trauma interventions.

🏅 Awards and Honors

Dr. Aila Gareayaghi has distinguished herself through numerous scientific contributions and recognitions. She has been invited as a speaker at prestigious forums such as the 59th National Psychiatry Congress and the Symposium on Disaster and Disaster Management. Her presentations on post-earthquake PTSD, antipsychotic-induced complications, and caregiver support have been recognized for their clinical relevance and academic rigor. Dr. Gareayaghi’s research, including peer-reviewed publications on telepsychiatry and transphobia in healthcare, reflects her innovative approach to contemporary psychiatric challenges. Although formal awards are not specified, her active involvement as Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye and her multiple invited speaker roles demonstrate high professional regard and peer recognition. Moreover, her extensive certifications in psychotherapy modalities underscore her commitment to lifelong learning and excellence in patient care. Her dedication to volunteer work and animal welfare also highlight her compassionate engagement beyond academia.

🔬 Research Focus

Dr. Gareayaghi’s research focuses primarily on trauma-informed care, disaster psychiatry, and telepsychiatry, with a special emphasis on the mental health impact of natural disasters. Her thesis work examined the prevalence of PTSD following Türkiye’s 2023 earthquakes and the effectiveness of telepsychiatry services during disaster recovery. Additionally, her research explores societal and clinical aspects of sexual dysfunction, major depressive disorder, bipolar disorder, schizophrenia, and anxiety disorders. She has published studies addressing transphobia in healthcare, antipsychotic-induced complications, and innovative therapeutic interventions such as EMDR. Dr. Gareayaghi integrates various therapeutic modalities, including dynamic psychotherapy, cognitive behavioral therapy, and psychodynamic psychotherapy, into both her clinical practice and research. Her multidisciplinary approach bridges clinical psychiatry, public health, and social psychology, contributing valuable insights into the management of psychiatric emergencies and the psychological aftermath of crises. Her ongoing work continues to address evolving mental health challenges in both individual and systemic contexts.

✅ Conclusion

Dr. Aila Gareayaghi exemplifies a dynamic psychiatrist integrating clinical excellence, cutting-edge research, and compassionate care, with a focus on trauma therapy, disaster psychiatry, telepsychiatry, and comprehensive psychiatric education.

Publications

  • Ruh Sağlığında Kriz

    ÖGDA GAREAYAGHİ, UDH YILMAZ, A POLAT
    PSİKİYATRİK ACİLLER
  • A MEDICAL STUDENT’S PERSPECTIVE ON ANIMAL EXPERIMENTATION.
    A Gareayaghi
    The Turkish Journal of Gastroenterology: the Official Journal of Turkish …

  • Predictors of Transphobia and Attitudes Toward Transgender Individuals Among Nurses in Türkiye: A Cross-Sectional Study

    Healthcare
    2025-06-19 | Journal article
    DOI: 10.3390/healthcare13121474
    CONTRIBUTORS: Ezgi Şişman; Mehtap Güngör; Aila Gareayaghi; Hanife Yılmaz; Aslıhan Polat

  • Post-Earthquake PTSD and the Role of Telepsychiatry: A Six-Month Follow-Up Study After the 2023 Kahramanmaraş Earthquakes

    Medicina
    2025-06-17 | Journal article
    DOI: 10.3390/medicina61061097
    CONTRIBUTORS: Aila Gareayaghi; Elif Tatlıdil; Ezgi Şişman; Aslıhan Polat

  • Experiences with Brexpiprazole in the Management of Agitation Due to Dementia in a University Clinic: A Case Series

    Kocaeli Üniversitesi Sağlık Bilimleri Dergisi
    2025-03-21 | Journal article
    DOI: 10.30934/kusbed.1617807
    CONTRIBUTORS: Aila Gareayaghi; Ezgi Şişman; Mert Türksoy; Aslıhan Özlem Polat Işık

Dyandevi mathure | Nanoformulation for Alzheimer’s disease | Best Researcher Award

Posted on by Cognitive Scientist Awards

Dr. Dyandevi mathure | Nanoformulation for Alzheimer’s disease | Best Researcher Award

Dr. Dyandevi Mewalal Mathure, Assistant Professor at Bharati Vidyapeeth, Poona College of Pharmacy, Pune, is a distinguished academician with over 15 years of experience in pharmaceutical sciences. Holding a Ph.D. in Pharmaceutical Sciences, she has significantly contributed to teaching, research, and innovation. Dr. Mathure has authored three notable books, published 18 research articles in reputed journals, and holds five published patents. Her research primarily focuses on nanoformulations for Alzheimer’s disease, wound healing, and topical formulations for skin diseases. She has successfully completed government-funded research projects and is actively engaged in industry consultancy work. Collaborating with institutions like the University of Petroleum and Energy Studies, Dehradun, Dr. Mathure continues to push the frontiers of pharmaceutical research. Her dedication is reflected in multiple accolades, including best paper presentation awards at international conferences. Committed to translational pharmaceutical advancements, she remains a passionate contributor to academia and industry alike.

Profile

🎓 Education

Dr. Dyandevi Mewalal Mathure earned her Ph.D. in Pharmaceutical Sciences, building a robust foundation in pharmaceutical research and innovation. Her academic journey has been characterized by a strong emphasis on novel drug delivery systems, formulation development, and translational research. She has engaged in continuous professional development, authoring several key texts in Industrial Pharmacy and Modern Dispensing Practices, which are widely used in academic curricula. Her educational background not only reflects depth in pharmaceutical sciences but also showcases her commitment to knowledge dissemination through teaching and publication. Her advanced training and research expertise in nanoformulations, brain-targeted drug delivery, and topical therapeutic systems underscore her position as a subject matter expert. Dr. Mathure’s education has enabled her to bridge theory and practice, equipping her with the skills to lead significant research projects, collaborate with industry partners, and mentor future pharmacists and researchers.

🧪 Experience

With over 15 years of academic and research experience, Dr. Dyandevi Mewalal Mathure has built a distinguished career as an Assistant Professor at Bharati Vidyapeeth, Poona College of Pharmacy, Pune. Her professional journey encompasses extensive teaching, research supervision, and collaborative research projects. She has published 18 papers in esteemed SCI and Scopus-indexed journals, authored three textbooks, and successfully filed five patents. Dr. Mathure has completed one funded research project and is currently engaged in an ongoing industry consultancy project, demonstrating her ability to translate academic research into practical applications. Her collaborations with institutions like the University of Petroleum and Energy Studies highlight her commitment to multidisciplinary research. Additionally, her expertise in nanoformulations for Alzheimer’s disease, wound healing, and skin disorders reflects her diverse research interests. Through her dedicated mentorship and active participation in international conferences, she continues to inspire and guide students, contributing significantly to the advancement of pharmaceutical sciences.

🏅 Awards and Honors

Dr. Dyandevi Mewalal Mathure has been recognized for her outstanding research contributions through multiple awards and honors. Notably, she received the Best Paper Presentation Award at the international e-Conference on “Expanding Frontier of Pharmaceutical Research Towards Global Exigency,” organized by Karpagam College of Pharmacy in association with the Indian Pharmaceutical Association, Coimbatore Branch. Her consistent scholarly excellence is reflected in her extensive publication record and successful patent filings. Dr. Mathure’s innovative work has garnered appreciation from both academia and industry, enhancing her reputation as a leader in pharmaceutical research. In addition to her academic accolades, her active involvement in consultancy projects further validates the real-world impact of her research. Her sustained commitment to innovation, teaching excellence, and translational research has made her a strong contender for the Best Research Award, recognizing her as a role model in the field of pharmaceutical sciences.

🔬 Research Focus

Dr. Dyandevi Mewalal Mathure’s research focuses on developing advanced nanoformulations aimed at treating Alzheimer’s disease, promoting wound healing, and addressing various dermatological conditions through innovative topical formulations. Her work emphasizes the design and optimization of novel drug delivery systems that enhance therapeutic efficacy and patient compliance. Through her publications, patents, and consultancy projects, Dr. Mathure has contributed to the advancement of brain-targeted drug delivery, an area critical for managing neurodegenerative diseases. Her translational research bridges laboratory discoveries with clinical and industrial applications, offering practical solutions to complex medical challenges. Collaborations with reputed institutions like UPES Dehradun further demonstrate her commitment to multidisciplinary and applied pharmaceutical research. With a citation index of 6, she maintains an active presence in scientific discourse, continuously advancing the boundaries of pharmaceutical sciences. Her work exemplifies innovation-driven research with tangible societal impact.

✅ Conclusion

Dr. Dyandevi Mewalal Mathure’s distinguished academic career, marked by impactful research in nanoformulations, drug delivery, numerous publications, patents, and active industry collaborations, demonstrates her unwavering commitment to advancing pharmaceutical sciences and improving patient care through innovation and translational research.

Publications

Jesus Avila | Tauopathies | Best Researcher Award

Posted on by Cognitive Scientist Awards

Prof. Jesus Avila | Tauopathies | Best Researcher Award

Dr. Jesus Avila is a distinguished cognitive scientist and Professor ad honorem at the Centro de Biologia Molecular Severo Ochoa (CBM-CSIC), Spain. He obtained his degree in Chemistry and PhD in Molecular Biology from Universidad Complutense Madrid, focusing on RNA polymerase in B. subtilis. His postdoctoral research at NIH, USA, centered on the SV40 virus. Throughout his prolific career, Dr. Avila has made groundbreaking contributions to understanding the neuronal cytoskeleton, particularly tau protein, its role in Alzheimer’s disease, and tauopathies. With over 694 published journal articles, 33 books, 4 patents, and collaborations across the USA, France, UK, Germany, and Spain, his work is internationally recognized. He serves on editorial boards of prestigious journals including EMBO J, FEBS Letters, Neuroscience, and Journal of Alzheimer’s Disease (Deputy Editor). Dr. Avila is a member of EMBO, Academia Europaea, AAAS, and Royal Academies of Sciences and Medicine of Spain.

Professional Profile

Education

Dr. Jesus Avila pursued his higher education at Universidad Complutense Madrid (UCM), earning a degree in Chemistry. He further specialized by completing a PhD in Molecular Biology at UCM, where his research focused on the B. subtilis RNA polymerase system. This solid foundation in molecular biology provided him with the expertise to investigate complex neurobiological mechanisms. He then advanced his academic career with postdoctoral training at the National Institutes of Health (NIH) in Bethesda, Maryland, USA, where he studied the SV40 virus—a crucial step that introduced him to advanced molecular virology and neurobiology techniques. This diverse academic background enabled him to establish a globally recognized research portfolio in neurodegeneration, particularly tau protein’s role in neuronal function and dysfunction.

Experience

Dr. Avila has an illustrious career spanning several decades at the Centro de Biologia Molecular Severo Ochoa (CBM-CSIC), where he has led pioneering research into the neuronal cytoskeleton, tau protein dysfunction, and neurodegenerative diseases. His early research at NIH on SV40 virus provided him with robust molecular expertise, which he translated into comprehensive studies on tauopathies and Alzheimer’s disease upon returning to Spain. Dr. Avila has successfully led over 30 major research projects, consulted on 8 industry collaborations, and published 694 peer-reviewed articles. His work includes the authorship of 33 books and the filing of 4 patents. Through sustained collaborations with global leaders in neuroscience from the USA, France, UK, Germany, and Spain, he has significantly advanced the understanding of aging and cognitive decline. His academic leadership and editorial roles underscore his vast experience in guiding both research and scientific discourse.

Research Interests

Dr. Avila’s research primarily investigates the neuronal cytoskeleton, with a central focus on tau protein and its role in neurodegeneration. Beginning with tau’s structural function in neurons, his work has expanded to explore how tau dysfunction contributes to Alzheimer’s disease and other tauopathies. Utilizing molecular and cellular approaches, including advanced mouse models, he has dissected the pathological mechanisms linking tau pathology to cognitive decline. Recognizing aging as the principal risk factor for Alzheimer’s disease, his current investigations target neuronal rejuvenation strategies to mitigate age-associated neurodegeneration. His integrative approach combines molecular biology, neurogenetics, and translational models, contributing significantly to the understanding of disease progression and potential therapeutic interventions. Through over 694 publications, 33 books, multiple patents, and international collaborations, Dr. Avila has substantially advanced the field of cognitive neuroscience, particularly in understanding and combating tau-mediated cognitive disorders.

Awards

Dr. Avila’s exemplary contributions have earned him numerous prestigious honors. He is an elected member of EMBO (European Molecular Biology Organization), Academia Europaea, AAAS (American Association for the Advancement of Science), and both the Royal Academies of Sciences and Medicine of Spain—testament to his global recognition and scientific excellence. His editorial appointments with highly respected journals such as EMBO J, FEBS Letters, Neuroscience, and his role as Deputy Editor of the Journal of Alzheimer’s Disease further validate his authority in cognitive and neurodegenerative research. His citation index surpasses 100 on Scopus, reflecting the significant influence of his work. His extensive collaborations with leading international research teams highlight his status as a respected leader in the global scientific community. The combination of his research excellence, mentorship, and leadership has positioned him as one of the foremost experts in cognitive science and neurobiology.

Conclusion

Dr. Jesus Avila’s distinguished career combines pioneering research on tau protein and Alzheimer’s disease, extensive international collaborations, over 694 publications, leadership roles in major journals, multiple prestigious memberships, and an unwavering focus on neuronal rejuvenation strategies, positioning him as a world-leading cognitive scientist whose work continues to advance global understanding of neurodegeneration.

 Publications

  • Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer’s disease

    Experimental Neurology
    2025 | Journal article
    DOI: 10.1016/j.expneurol.2024.115049

    EID:

    2-s2.0-85208758184

    Part ofISSN: 10902430 00144886
    CONTRIBUTORS: Merino-Serrais, P.; Soria, J.M.; Arrabal, C.A.; Ortigado-López, A.; Esparza, M.Á.G.; Muñoz, A.; Hernández, F.; Ávila, J.; DeFelipe, J.; León-Espinosa, G.

  • Retrotransposon Protein L1 ORF1p Expression in Aging Central Nervous System

    International Journal of Molecular Sciences
    2025-05-04 | Journal article
    DOI: 10.3390/ijms26094368
    CONTRIBUTORS: Laura Vallés-Saiz; Aaron Abdelkader-Guillén; Jesús Ávila; Félix Hernández

  • Shapeshifter W-Tau Peptide Inhibits Tau Aggregation and Disintegrates Paired Helical Filaments

    Biochemistry
    2025-04-15 | Journal article
    DOI: 10.1021/acs.biochem.4c00809
    CONTRIBUTORS: Indalo Domene-Serrano; Raquel Cuadros; Vega García-Escudero; Francisco Vallejo-Bedia; Ismael Santa-María; Laura Vallés-Saiz; Félix Hernandez; Jesús Avila

  • Peptide Family Promotes Brain Cell Rejuvenation and Improved Cognition through Peripheral Delivery

    ACS Omega
    2025-04-08 | Journal article
    DOI: 10.1021/acsomega.4c10849
    CONTRIBUTORS: Alejandro Anton-Fernandez; Indalo Domene-Serrano; Raquel Cuadros; Rocio Peinado-Cahuchola; Margarita Sanchez-Pece; Felix Hernandez; Jesus Avila

  • Partial reprogramming by cyclical overexpression of Yamanaka factors improves pathological phenotypes of tauopathy mouse model of human Alzheimer\’s disease

    Progress In Neurobiology
    2025-04-01 | Journal article | Author
    DOI: 10.1016/j.pneurobio.2025.102743

    SOURCE-WORK-ID:

    CSIC-GB950859

    EID:

    2-s2.0-85219079150

    Part ofISSN: 0301-0082
    CONTRIBUTORS: Alejandro Anton-Fernandez; Ruiz de Alegría, Álvaro; Mariscal-Casero, Ana; Roldán-Lázaro, Marta; Peinado-Cauchola, Rocío; Jesus Avila; Felix Hernandez

  • Hippocampal rejuvenation by a single intracerebral injection of one‐carbon metabolites in C57BL6 old wild‐type mice

    Aging Cell
    2025-01 | Journal article
    DOI: 10.1111/acel.14365
    CONTRIBUTORS: Alejandro Antón‐Fernández; Rocío Peinado Cauchola; Félix Hernández; Jesús Ávila

  • Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3

    eBioMedicine
    2024 | Journal article
    DOI: 10.1016/j.ebiom.2023.104953

    EID:

    2-s2.0-85181837483

    Part ofISSN: 23523964
    CONTRIBUTORS: Ruiz-Gabarre, D.; Vallés-Saiz, L.; Carnero-Espejo, A.; Ferrer, I.; Hernández, F.; Garcia-Escudero, R.; Ávila, J.; García-Escudero, V.

  • Involvement of the cellular prion protein in seeding and spreading of sarkosyl-derived fractions of Alzheimer´s disease in Prnp mutant mice and in the P301S transgenic tauopathy mice model

    bioRxiv
    2024 | Other
    DOI: 10.1101/2024.01.20.576414

    EID:

    2-s2.0-85184321414

    Part of ISSN: 26928205
    CONTRIBUTORS: Sala-Jarque, J.; Gil, V.; Andrés-Benito, P.; Lidón, L.; Yanac-Huertas, R.E.; López-León, C.F.; Hernández, F.; Ávila, J.; Lanciego, J.L.; Soriano, J. et al.

Konrad Talbot | Alzheimer’s Disease | Best Researcher Award

Posted on by Cognitive Scientist Awards

Assos. Prof. Dr. Konrad Talbot | Alzheimer’s Disease | Best Researcher Award

Dr. Konrad Talbot is a distinguished neuroscientist and Associate Professor at Loma Linda University School of Medicine, serving in the Departments of Neurosurgery, Pathology & Human Anatomy, and Basic Sciences since 2018. He specializes in investigating the pathogenesis and treatment of neurodegenerative and psychiatric disorders, particularly focusing on brain insulin resistance in Alzheimer’s and Parkinson’s diseases. With a Ph.D. in Physiological Psychology from UCLA and extensive postdoctoral training at the University of Pennsylvania, Dr. Talbot has held faculty and research positions at leading institutions such as Cedars-Sinai, UCLA, and UPenn. He is a highly cited researcher (H-index: 34, 9341 citations), with significant NIH and international grant support. He also serves as an editorial board member, reviewer, and invited speaker at global conferences. His work has influenced both fundamental neuroscience and the development of therapeutic strategies for brain diseases.

Profile

🎓 Education

Dr. Konrad Talbot completed his undergraduate (B.A.), master’s (M.A.), and doctoral (Ph.D.) degrees in Psychology with a specialization in Physiological Psychology at the University of California, Los Angeles (UCLA). His academic path reflects a deep commitment to understanding the biological underpinnings of behavior and brain function. He also received formal teaching certification from UCLA’s Instructor Development Program in 1992. His postdoctoral training included pivotal roles at the University of Pennsylvania’s Department of Pathology and Laboratory Medicine and the Center for Neurodegenerative Disease Research (1997–2001), where he developed expertise in brain autopsy and pathology. He furthered his technical capabilities through advanced training in quantitative fluorescence microscopy at Mount Desert Island Biological Laboratory in 2007. His broad educational background forms a strong foundation for his interdisciplinary research and teaching roles across psychology, neurobiology, pathology, and medical sciences.

🧪 Experience

Dr. Talbot’s academic journey spans over three decades, beginning as an Assistant Professor at Mount St. Mary’s College and St. Olaf College, where he taught psychology and mentored numerous students. He transitioned into intensive research roles at the University of Pennsylvania (UPenn) from 1997 to 2012, ascending from postdoctoral investigator to senior research investigator and research faculty. He later held associate research professorships at Cedars-Sinai Medical Center and UCLA. Since 2018, he has served as Associate Professor at Loma Linda University. Dr. Talbot has authored influential studies on brain insulin resistance, taught neuroanatomy to medical residents, supervised postdoctoral and undergraduate research projects, and served in various academic leadership and committee roles. In addition to his research and teaching, he has contributed editorial expertise to high-impact journals and consulted on landmark neuroanatomical atlases. His career reflects a blend of teaching excellence, pioneering research, and interdisciplinary leadership.

🏅 Awards and Honors

Dr. Talbot’s contributions have been widely recognized through prestigious awards and honors. In 2003, he received the T.L.L. Temple Foundation Discovery Award from the Alzheimer’s Association for his groundbreaking work on brain insulin resistance. He was honored as a co-dedicatee of the influential neuroscience text The Mouse Brain in Stereotaxic Coordinates (2008 edition), highlighting his impact on anatomical brain mapping. In 2020, he was inducted into the Sigma Chi Scientific Research Honor Society. His professional affiliations include long-standing memberships with the Society for Neuroscience, Alzheimer Research Forum, Schizophrenia Research Forum, and ISTAART (International Society to Advance Alzheimer Research and Treatment). He has played leadership roles in organizing major scientific conferences, chaired institutional committees, and served on advisory panels. His editorial contributions and invited lectures worldwide further underscore the scientific community’s high regard for his research excellence and thought leadership.

🔬 Research Focus

Dr. Talbot’s research centers on identifying and targeting mechanisms underlying neurodegenerative and psychiatric diseases, with a special emphasis on insulin resistance in the brain. He has pioneered investigations showing that brain insulin resistance plays a critical role in Alzheimer’s and Parkinson’s disease pathogenesis. His NIH-funded work explores the therapeutic potential of incretin receptor agonists—an emerging class of antidiabetics—in reducing brain insulin resistance and improving cognitive function. His collaborative projects with institutions like CUNY, UCLA, and the University of Washington focus on both human brain tissue analysis and preclinical models. Past research includes the molecular biology of schizophrenia, especially dysbindin-related pathways. He holds a U.S. patent application on methods for treating brain insulin resistance, signaling the translational potential of his findings. Dr. Talbot’s research integrates neuropharmacology, pathology, neuroanatomy, and clinical neuroscience, aiming to develop disease-modifying treatments that can halt or reverse progression in cognitive and psychiatric disorders.

✅ Conclusion

Dr. Konrad Talbot is an accomplished neuroscientist whose multidisciplinary work in brain insulin resistance has significantly advanced understanding and treatment approaches for Alzheimer’s and Parkinson’s diseases, blending rigorous research, impactful teaching, and translational innovation.

Publications

Mai Osman Mohamed Kadry | Biochemistry | Best Researcher Award

Posted on by Cognitive Scientist Awards

Assist. Prof. Dr. Mai Osman Mohamed Kadry | Biochemistry | Best Researcher Award

Assist. Prof. Dr. Mai O.Kadry,National Research Center, Egypt

Dr. Mai Osman Mohamed Kadry is a distinguished biochemistry researcher at the Therapeutic Chemistry Department, National Research Centre, Egypt. With a Doctorate in Biochemistry from Cairo University (2016), her work focuses on oxidative injury, nanotoxicity, and cancer therapy. She has published extensively in high-impact journals on topics like antioxidant effects, stem cell therapies, and metabolic disorders. Dr. Kadry has also contributed to academia, teaching pharmacognosy at 6th October University. Skilled in advanced techniques like PCR, HPLC, and ELISA, she actively participates in groundbreaking nanobiotechnology research projects. Dr. Kadry is committed to advancing therapeutic strategies for critical diseases. 📚🧬

Profile

🎓 Education

Assist. Prof. Dr. Mai O. Kadry boasts a strong academic foundation in pharmaceutical sciences. She earned her Doctorate in Biochemistry from the Faculty of Pharmacy, Cairo University, in 2016, with a thesis on the “Amelioration of Nano-Sized Titanium Dioxide-Induced Oxidative Injury in Mice by Some Antioxidants.” She obtained her Master’s degree in Pharmaceutical Sciences from Helwan University in 2008, focusing on the synergistic effects of phytic and catechin on carbon tetrachloride-induced damage in rats. Dr. Kadry completed her B.Sc. in Pharmaceutical Science at Ain Shams University in 2003, graduating with honors. She also attended English language schools, enhancing her global communication skills. 🌟🔬

🧪 Experience

Assist. Prof. Dr. Mai O. Kadry has accumulated valuable experience in academia and research. She served as a pharmacognosy instructor at the Faculty of Pharmacy, 6th October University, Cairo, Egypt (2003–2004), where she effectively delivered courses on natural products and their therapeutic applications. Dr. Kadry also contributed as a staff member focused on development and quality enhancement, aligning with the standards of the National Commission for Academic Accreditation. Her dedication to education and quality assurance reflects her commitment to fostering academic excellence and professional growth in pharmaceutical sciences. 📚🔬

Training 🧬📚

Assist. Prof. Dr. Mai O. Kadry has undergone extensive training in various scientific disciplines. She completed courses in Biostatistics (November 2016) and Bioinformatics (January 2017) at the National Research Centre. Earlier, she gained expertise in Scientific Typewriting Bases (March 2007) and Occupational Health and Safety (June 2009). Additionally, she mastered Protein Electrophoresis through a four-month course in 2006. Dr. Kadry enhanced her practical skills with hands-on training at Al-Borg Clinical Laboratory, focusing on PCR techniques for detecting HBV and HCV at the Theodor Bilharz Research Institute. Her comprehensive training equips her with valuable laboratory and analytical skills. 🔬🧪

🔬 Research Focus

Assist. Prof. Dr. Mai O. Kadry focuses on cutting-edge biomedical research, emphasizing toxicity, cancer therapy, and molecular biology. Her work explores inflammatory mediators, DNA damage, and therapeutic approaches in liver, brain, and nephrotoxicity contexts. She investigates autophagy, necroptosis, and novel strategies like resveratrol nano-formulations for ovarian cancer. Dr. Kadry also studies molecular pathways in gastric and prostate cancers, including miRNA-lncRNA signaling and CRISPR-Cas9 applications. Other interests involve genetic mutations in leukemia, drug-delivery systems, and nanotechnology for breast cancer. Her contributions bridge diagnostics, therapeutic innovations, and cellular mechanisms in oncology and toxicology. 🔬✨

✅ Conclusion

Assist. Prof. Dr. Mai O. Kadry is a distinguished biochemistry researcher whose work bridges advanced molecular biology and therapeutic innovation. With expertise in nanotoxicity, oxidative injury, and cancer therapy, she contributes significantly to biomedical science through impactful research and academic leadership. Her training in cutting-edge techniques and her focus on translational medicine position her at the forefront of scientific discovery. Dr. Kadry’s dedication to improving healthcare through targeted therapies and her commitment to academic excellence make her a valuable asset to the scientific community. Her career reflects passion, innovation, and a relentless pursuit of better treatment solutions.

 

Publications

  • Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia: a comparative study

    Future Science OA
    2024-12-31 | Journal article
    DOI: 10.2144/fsoa-2023-0111
    CONTRIBUTORS: Mai O Kadry; Abdel-Hamid Z Abdel Hamid; Rehab M Abdel-Megeed

  • Fischer’s oligopeptide ratio in ischemic hypoxia: prophylactic amendment of sophoretin and melatonin supplementation

    Future Science OA
    2024-12-31 | Journal article
    DOI: 10.2144/fsoa-2023-0117
    CONTRIBUTORS: Mai O Kadry; Hanaa Mahmoud Al

  • Thioctic acid shield against lipopolysaccharide depression and endoplasmic reticulum stress: GR7M/Homer/ATF6 signaling

    Future Science OA
    2024-12-31 | Journal article
    DOI: 10.1080/20565623.2024.2422791
    CONTRIBUTORS: Mai O. Kadry; Rehab M. Abdel-Megee

Adithi Randeni | Transcytosis Mechanisms and Hydrocephalus Pathophysiology | Best Researcher Award

Posted on by Cognitive Scientist Awards

Dr. Adithi Randeni | Transcytosis Mechanisms and Hydrocephalus Pathophysiology | Best Researcher Award

Leeds Teaching Hospitals Trust, United Kingdom

Dr. Randeni A. Adithi H. Randeni is a Foundation Year One doctor at Leeds Teaching Hospital Trust with a dynamic portfolio in clinical research, innovation, and academic leadership. A graduate of the University of Leeds (MBChB), she has gained international exposure through observerships and research collaborations in the UK and USA, including SUNY Upstate. Her scholarly contributions span neurosurgery, cerebrospinal fluid dynamics, and biomedical innovation, with publications in top-tier journals such as IJMS, BJS, and BMC Medical Education. Dr. Randeni has received numerous awards and bursaries and is an active educator and mentor. Her leadership roles in university bodies and national societies reflect her commitment to academic excellence and inclusivity. With a future goal of specializing in neurosurgery, she aims to contribute to translational research and advance surgical practice globally through innovation and collaboration.

Profile

🎓 Education

Dr. Adithi Randeni earned her Bachelor of Medicine and Bachelor of Surgery (MBChB) from the University of Leeds, where she excelled in both academic and research endeavors. Her education was enriched by multiple research projects and electives across the UK and internationally, including SUNY Upstate Medical University in the USA. During her time at Leeds, she engaged deeply with translational research, contributing to projects on hydrocephalus, tissue engineering, neurotrauma, and breast cancer genetics. Her academic training included structured research programs and specialized modules in biomedical innovation, CSF dynamics, and advanced surgical techniques. She also undertook audits, systematic reviews, and service evaluations during clinical placements. Beyond formal education, she participated in national research fellowships and student interest groups that fostered interdisciplinary learning and mentorship. Dr. Randeni’s educational journey reflects a strong integration of clinical knowledge with scientific inquiry, preparing her for a future as a research-driven neurosurgeon and academic leader.

🧪 Experience

Dr. Adithi Randeni currently serves as a Foundation Year One doctor at Leeds Teaching Hospital Trust, where she is engaged in hands-on patient care, audits, and quality improvement projects. She has amassed extensive research experience through clinical, translational, and lab-based projects, including those at SUNY Upstate and the University of Leeds. Her past roles include conducting systematic reviews, performing service evaluations in neurosurgery, and leading national student surveys like SMART. She has presented her findings at both national and international conferences and has co-authored peer-reviewed articles and a book chapter. In addition to clinical duties, she has held leadership roles in student organizations, served as a medical student representative, and organized educational workshops. Her involvement with professional societies and interdisciplinary teams highlights her ability to balance clinical work, academic productivity, and collaborative initiatives, making her a well-rounded early-career professional with a clear trajectory in neurosurgical research and innovation.

🏅 Awards and Honors

Dr. Adithi Randeni has been the recipient of numerous academic awards, conference bursaries, and leadership recognitions during her medical training. Her achievements include international presentation opportunities and publication accolades for research on hydrocephalus, surgical outcomes, and student engagement in research pathways. She was invited to co-author a chapter in Springer’s “Arachnoid Cysts: State-of-the-Art” and has contributed to high-impact journals like the British Journal of Surgery and BMC Medical Education. She has earned research travel grants, elective placement scholarships, and teaching recognitions for organizing peer education workshops. Active in student leadership, she received commendations for her roles within the Medical Student Representative Council and societies such as NANSIG and the National MedTech Foundation. Her selection for the “Best Researcher Award” nomination reflects her growing influence in academic medicine. These honors affirm her commitment to excellence in research, innovation, and medical education at an early stage of her professional journey.

🔬 Research Focus

Dr. Adithi Randeni’s research focus lies at the intersection of neurosurgery, cerebrospinal fluid (CSF) dynamics, and biomedical innovation. She has explored pathological mechanisms such as abnormal transcytosis in hydrocephalus, authored a chapter on the genetics of arachnoid cysts, and is actively investigating CSF composition in hydrocephalus through collaborations with SUNY Upstate. Her research interests also include neurotrauma, surgical outcomes, antimicrobial stewardship, and tissue-engineered cardiovascular grafts. With a strong inclination toward translational research, she integrates clinical insights with lab-based findings to drive innovation. Dr. Randeni also explores medical education, having co-led the SMART study on student engagement in research. Her contributions aim to bridge the gap between bedside care and bench science, with ongoing work assessing surgical site infections and diagnostic accuracy in neurosurgical imaging. She is passionate about leveraging biomedical research and digital tools to enhance patient outcomes and surgical practice, particularly in underserved and complex neurological conditions.

✅ Conclusion

Dr. Adithi Randeni exemplifies the fusion of clinical excellence, research innovation, and educational leadership, positioning her as a promising future leader in neurosurgery and translational science.

Publications

  • Abnormal Transcytosis Mechanisms in the Pathogenesis of Hydrocephalus: A Review

    International Journal of Molecular Sciences
    2025-05-19 | Journal article
    DOI: 10.3390/ijms26104881
    Part ofISSN: 1422-0067
    CONTRIBUTORS: Adithi Randeni; Sydney Colvin; Satish Krishnamurthy

  • Genetics of Arachnoid Cysts

    Arachnoid Cysts
    2023 | Book chapter
    DOI: 10.1007/978-3-031-22701-1_8
    Part ofISBN: 9783031227004
    Part ofISBN: 9783031227011
    CONTRIBUTORS: Adithi Randeni; Sydney Colvin; Satish Krishnamurth

  • Cross-sectional Survey of Medical student perceptions of And desires for Research and Training pathways (SMART): an analysis of prospective cohort study of UK medical students

    BMC Medical Education
    2023-12-15 | Journal article
    DOI: 10.1186/s12909-023-04881-2
    Part of ISSN: 1472-6920
    CONTRIBUTORS: Gokul Parameswaran; Amelia Bowman; Catherine Swales; Setthasorn Zhi Yang Ooi; Shie Wei Chan; Priya Rose Babu; Daniele Ramsay; Sofia Kostoudi; Soham Bandyopadhyay; SMART-NANSIG-InCiSion Collaborative et al.

Timea Claudia Ghitea | Metabolic Syndrome | Women Researcher Award

Posted on by Cognitive Scientist Awards

Dr. Timea Claudia Ghitea | Metabolic Syndrome | Women Researcher Award

Universitary Assistant, University of Oradea, Romania

GHITEA TIMEA-CLAUDIA is a Romanian expert in pharmacy and clinical nutrition, with over two decades of professional experience combining pharmaceutical practice, clinical and sports nutrition, and academic teaching. She currently serves as a university assistant at the Faculty of Medicine and Pharmacy in Oradea and leads nutrition initiatives at Echo Laboratories. Her career began in 1999 as a pharmacy assistant, advancing through key leadership roles, including pharmacist director in various pharmacies. Holding dual specialization in pharmacy and biomedical sciences, Dr. Ghitea completed her doctorate in Clinical and Sports Nutrition in 2020. A multilingual professional, she is committed to interdisciplinary collaboration and student mentorship. Her dynamic profile is strengthened by memberships in national and international professional societies. She also contributes actively to administrative roles in academic and pharmaceutical organizations. Dr. Ghitea is a respected voice in the evolving field of clinical nutrition and personalized healthcare in Romania.

Profile

🎓 Education

GHITEA TIMEA-CLAUDIA holds a robust academic portfolio encompassing both pharmaceutical and biomedical disciplines. She earned her Doctorate in Biomedical Sciences with a focus on Clinical and Sports Nutrition in 2020 and completed postgraduate studies in Nutrition and Dietetics in 2017. Her foundational studies include a Master’s degree in Cell Biology (2006), a Pharmacy degree from the Faculty of Medicine and Pharmacy in Oradea (2006), and a Bachelor of Science in Biology-Chemistry (2002). She also holds a diploma as a Pharmacy Assistant from the Vasile Voiculescu Post-High School (1999) and graduated high school from Ady Endre Theoretical High School in 1997. She has continuously enhanced her expertise through specializations such as a residency in Clinical Pharmacy (2009) and various professional training programs. Her academic involvement is complemented by her roles in professional boards and committees, contributing significantly to pharmacy and nutrition education in Romania.

🧪 Experience

GHITEA TIMEA-CLAUDIA brings more than 25 years of hands-on experience in pharmacy, healthcare, and academia. Since 2017, she has served as a university assistant at the Faculty of Medicine and Pharmacy, Oradea, while also leading clinical and sports nutrition services at Echo Laboratories. Previously, she was pharmacist director at Serbien Pharmacy (2012–2017) and MIG3 Pharmacy (2011–2012). Her career began as a pharmacy assistant at Delia Pharmacy (1999–2006), followed by a pharmacist role at Fontana Pharmacy (2006–2011). A proactive mentor and project leader, she supervises internships and facilitates interdisciplinary collaboration to address complex patient cases in nutrition. Her leadership extends to project management and service coordination in clinical nutrition. Her deep understanding of pharmacy and dietetics, combined with strong communication, organizational, and mentoring skills, ensures her consistent contribution to healthcare innovation and medical education. She effectively bridges academic knowledge with clinical application and professional governance.

🏅 Awards and Honors

GHITEA TIMEA-CLAUDIA has earned recognition through key leadership roles and active participation in prominent professional associations. She was appointed President of the Discipline Committee at the College of Pharmacists, Bihor, in 2011, and later served as a member of both the General Assembly and the Discipline Committee. Her involvement spans national and international professional societies, including the American Society for Nutrition (2017), the Romanian Society of Pharmaceutical Sciences (2019), and the Pharmacological Association of Romania (since 2006). She is also a member of the Nutritionists Association of Romania (2022) and the Society of Pharmaceutical History Romania (2019). Her consistent efforts in academic mentorship earned her the role of Internship Mentor, and she was designated Project Manager in 2022. These accolades underscore her leadership, dedication to advancing pharmacy and nutrition sciences, and her commitment to mentoring future professionals. Her honors reflect a sustained contribution to both clinical practice and scholarly engagement.

🔬 Research Focus

Dr. GHITEA TIMEA-CLAUDIA’s research focus lies at the intersection of clinical pharmacy, sports nutrition, and biomedical science. Her work is dedicated to optimizing patient care through evidence-based nutritional strategies and the integration of pharmaceutical knowledge into personalized dietetic plans. Her doctoral studies in Clinical and Sports Nutrition laid the foundation for a research trajectory that includes metabolic optimization, nutritional therapy in chronic diseases, and the role of diet in athletic performance and recovery. She actively collaborates with international colleagues to solve complex clinical nutrition cases and contributes to interdisciplinary projects aimed at enhancing nutritional interventions. As a university assistant and project leader, she mentors students in clinical research methodology, practical case-solving, and the application of nutritional science in medical contexts. Her expertise is instrumental in bridging academic insights with real-world patient outcomes, promoting innovation in clinical nutrition and pharmacy-driven healthcare models.

✅ Conclusion

Dr. Ghitea Timea-Claudia is a dynamic healthcare professional whose career seamlessly bridges pharmaceutical science, clinical nutrition, and academic leadership. Her vast experience, ongoing research, and dedication to student mentorship reflect her holistic and forward-thinking approach to health education and patient care.

Publications

  • Vaccine Adherence: From Vaccine Hesitancy to Actual Vaccination and Reasons for Refusal of Childhood Vaccines in a Group of Postpartum Mothers

    In Vivo
    2025 | Journal article
    DOI: 10.21873/INVIVO.13855
    WOSUID: WOS:001391824800006
    CONTRIBUTORS: Iova, Camelia florina; Daina, Lucia georgeta; Ilea, Codrin dan nicolae; Domnariu, Horatiu Paul; Ghitea, Timea claudia; Daina, Madalina Diana Daina

  • The Impact of Thrombophilia on Maternal and Neonatal Outcomes: A Multisystem Analysis of Clinical, Hematological, and Metabolic Parameters

    Journal of Clinical Medicine
    2025-05-23 | Journal article
    DOI: 10.3390/jcm14113665
    CONTRIBUTORS: Viorela-Romina Murvai; Radu Galiș; Cristina-Maria Macrea; Anca-Florina Tărău-Copos; Marius Daniel Goman; Timea Claudia Ghitea; Anca Huniadi

  • Stomatognathic Dysfunction and Neuropsychological Imbalance: Associations with Salivary Cortisol, EMG Activity, and Emotional Distress

    Dentistry Journal
    2025-05-22 | Journal article
    DOI: 10.3390/dj13060230
    CONTRIBUTORS: Ioana Scrobota; Liliana Sachelarie; Timea Claudia Ghitea; Georgiana Ioana Potra Cicalau; Roxana Alexandra Cristea; Pelea Diana; Petra Saitos; Alexandra Vlad; Loredana Liliana Hurju

  • Correlation Between Vitamin D Deficiency (25(OH)D3) and the Severity of Purulent Oropharyngeal Infections

    Journal of Clinical Medicine
    2025-04-01 | Journal article
    DOI: 10.3390/jcm14072410
    CONTRIBUTORS: Florian Ciprian Venter; Timea Claudia Ghitea; Adrian Nicolae Venter; Amin-Florin El-kharoubi; Mousa El-kharoubi; Evelin Claudia Ghitea; Marc Cristian Ghitea; Amina Vente

  • Psychological Distress and Quality of Life in Patients with Colon Cancer: Predictors, Moderating Effects, and Longitudinal Impact

    Healthcare
    2025-03-27 | Journal article
    DOI: 10.3390/healthcare13070753
    CONTRIBUTORS: Lavinia Alina Rat; Timea Claudia Ghitea; Adrian Marius Maghiar

Yingna Le | Research on the Mechanism of Action of Active Ingredients in Traditional Chinese Medicine | Best Researcher Award

Posted on by Cognitive Scientist Awards

Dr. Yingna Le | Research on the Mechanism of Action of Active Ingredients in Traditional Chinese Medicine | Best Researcher Award

PhD Candidate| Nanchang Medical College, china

Dr. Yingna Le is a Lecturer in Pharmacy at Nanchang Medical College’s School of Pharmacy, where she specializes in pharmacognosy and the authentication of Chinese medicinal materials. With a strong foundation in Chinese Materia Medica from Yunnan and Jiangxi Universities of Traditional Chinese Medicine, she combines traditional knowledge with modern scientific research. Dr. Le actively investigates the molecular mechanisms behind active ingredients in Traditional Chinese Medicine (TCM), contributing to national and provincial research projects. Her work includes the study of hawthorn leaf flavonoids and kidney stone treatments through the lens of network pharmacology and gut-liver axis analysis. She has published in core Chinese and international journals, developed flipped classroom models, and innovated WeChat-based educational tools. A member of several professional societies, she is committed to advancing TCM education and research. Her interdisciplinary approach integrates experimental design, pharmacognosy, and data analysis to enrich teaching and contribute to the scientific community.

Profile

🎓 Education

Dr. Yingna Le holds both Bachelor’s and Master’s degrees in Chinese Materia Medica. She earned her B.S. from Yunnan University of Traditional Chinese Medicine in 2007, where she developed a strong understanding of traditional pharmacognosy and the foundational principles of Chinese medicine. She then pursued her M.S. from Jiangxi University of Traditional Chinese Medicine (2008–2011), deepening her expertise in medicinal material authentication and TCM pharmacology. Her postgraduate studies provided her with skills in microscopic identification, phytochemical analysis, and TCM theory, setting the stage for her research and teaching career. This rigorous academic background enabled her to bridge the gap between traditional practices and contemporary scientific methods. Her educational journey laid the groundwork for her future roles in academia and research, where she continues to explore the integration of modern pharmacological techniques with ancient herbal wisdom. Dr. Le’s academic path demonstrates her dedication to excellence and innovation in the field of TCM.

🧪 Experience

Dr. Yingna Le currently serves as a Lecturer in the School of Pharmacy at Nanchang Medical College (2021–present), where she teaches Pharmacognosy and the Authentication of Chinese Medicinal Materials. Prior to this, she was a Teaching Assistant at the Jiangxi University of TCM Science and Technology College (2018–2021), where she began integrating innovative teaching strategies into traditional Chinese medicine education. Her academic career is marked by a dedication to improving teaching quality through flipped classrooms and the application of digital platforms like WeChat for student engagement and evaluation. In addition to teaching, Dr. Le has played pivotal roles in research, particularly as Principal Investigator and Co-Investigator on national and provincial research grants. She has completed five interdisciplinary projects between 2020 and 2022 and actively contributes to academic publications. Her blend of instructional innovation and research acumen makes her a respected figure in both educational and scientific circles in TCM.

🏅 Awards and Honors

Dr. Yingna Le has earned recognition through competitive research funding and influential academic appointments. She is the Principal Investigator of a Jiangxi Provincial Education Department grant for studying Lygodium japonicum’s mechanisms against kidney stones, and a Co-Investigator on a prestigious National Natural Science Foundation of China (NSFC) grant examining hawthorn leaf flavonoids in cardiovascular treatment. While specific award titles are not listed, her success in securing these high-level grants reflects her scientific credibility and innovation. Additionally, her involvement in five interdisciplinary education reform and material science projects (2020–2022) with substantial budgets highlights her leadership and collaborative spirit. Dr. Le also holds committee roles in key professional societies, including the TCM Processing Committee of the Jiangxi Pharmaceutical Association and the Digital Healthcare & Simulation Medicine Society of Jiangxi Province. These roles further affirm her status as a trusted contributor to the advancement of pharmacy education and research in Traditional Chinese Medicine.

🔬 Research Focus

Dr. Yingna Le’s research centers on uncovering the mechanisms of action of active ingredients in Traditional Chinese Medicine using modern pharmacological approaches. Her work focuses on compounds such as hawthorn leaf flavonoids and their effects on cardiovascular health, particularly unstable plaques, through the LXR-α mediated modulation of iron-lipid metabolism in the gut-liver axis. She also investigates the therapeutic potential of Lygodium japonicum in kidney stone treatment via network pharmacology. Dr. Le employs a range of methodologies including phytochemical analysis, molecular mechanism studies, and pharmacognostic techniques. Her research approach integrates traditional herbal knowledge with systems biology to bridge classical TCM theory with modern biomedical science. She has a strong interest in interdisciplinary collaboration and has led or contributed to numerous research projects across pharmacology, education reform, and material science. Her contributions aim to validate and modernize the application of traditional remedies in contemporary clinical settings, making her work both culturally relevant and scientifically impactful.

✅ Conclusion

Dr. Yingna Le blends traditional Chinese medical expertise with modern research to advance pharmacognosy and medicinal authentication. Through dedicated teaching, impactful research, and innovative education methods, she contributes significantly to TCM modernization.

Publications

Alihossein saberi | Male infertility | Outstanding Scientist Award

Posted on by Cognitive Scientist Awards

Dr. Alihossein saberi | male infertility | Outstanding Scientist Award

professor| Ahwaz Jundishapour University of  Medical Sciences, Iran

Dr. Alihossein Saberi is an accomplished molecular geneticist and Associate Professor at Ahvaz Jundishapur University of Medical Sciences. With a career spanning over three decades, he has held several academic and administrative positions, including Head of the Department of Medical Genetics. He earned his PhD in Molecular Medicine from Kyoto University, Japan, following a master’s in Radiation Biology from Tarbiat Modarres University, Iran. Dr. Saberi has taught and mentored extensively in molecular biology, genetics, and radiation biology. He has authored numerous research articles and textbooks, contributing significantly to the field of molecular genetics, particularly in cancer genomics, male infertility, and genetic disorders. He remains deeply involved in collaborative international research. Dr. Saberi is known for integrating teaching, administration, and impactful research to advance medical genetics education and practice in Iran and beyond.

Profile

🎓 Education

Dr. Saberi earned his PhD in Molecular Medicine from the Graduate School of Medicine at Kyoto University, Japan, between 2004 and 2007. Prior to this, he underwent a research traineeship at the same institution from 2003 to 2004. He completed his Master of Science in Radiation Biology in 1992 at Tarbiat Modarres University, Tehran, Iran, where he gained strong foundational knowledge in biomedical sciences. His education trajectory reflects a continuous focus on molecular and cellular biology, particularly genetic mechanisms underlying human health and disease. His exposure to international research environments has significantly shaped his academic and professional outlook, equipping him with advanced techniques in gene expression, molecular diagnostics, and cancer genomics. These academic qualifications have been central to his role in establishing and leading educational and research initiatives in medical genetics in Iran, enhancing both curriculum development and translational research in the domain of human genetics.

🧪 Experience

Dr. Saberi began his academic career in 1992 as a lecturer at Ahvaz Jundishapur University of Medical Sciences, advancing to Assistant Professor (2007–2013), Associate Professor (since 2013), and Head of the Department of Medical Genetics (since 2014). He also served as Deputy of Educational Affairs (1998–1999) and Dean of the Paramedical Faculty (1999–2003), showcasing his administrative leadership. Over the years, he has taught various core subjects such as Molecular Biology, Medical Genetics, and Radiation Biology. His teaching spans over 30 years and is supported by a strong research portfolio and international collaborations. His leadership has led to the development of molecular genetics curricula and enhanced the university’s role in medical genetics research and diagnostics. His blend of academic, research, and administrative roles reflects a holistic contribution to the medical education and healthcare system in Iran, making him a key figure in advancing genetics education and clinical research in the region.

🏅 Awards and Honors

Dr. Alihossein Saberi’s professional excellence is recognized through his appointment as Head of the Department of Medical Genetics and his pivotal role in curriculum reform and academic leadership at Ahvaz Jundishapur University of Medical Sciences. Although specific awards are not listed, his career progression—from lecturer to associate professor and departmental head—underscores recognition of his academic contributions. His participation in international collaborations and co-authorship of high-impact publications in renowned journals such as Genetics in Medicine, Clinical Genitourinary Cancer, and International Journal of Biological Macromolecules reflects international recognition and scientific credibility. Authoring textbooks in Persian further demonstrates his commitment to knowledge dissemination in the native language. His contributions to both education and research continue to position him as a respected expert in the Iranian academic community and an influential collaborator on global genetic research projects, often cited for his work in oncology, neurogenetics, and reproductive genetics.

🔬 Research Focus

Dr. Saberi’s research focuses on molecular genetics with special emphasis on cancer biology, reproductive genetics, and genetic basis of neurodevelopmental disorders. He explores the regulatory role of microRNAs, gene polymorphisms, and novel genetic markers in disease susceptibility and progression. Recent studies include investigations on microRNA-32 in prostate cancer, FSHB polymorphisms in male infertility, and co-delivery of gene therapies in hepatocellular carcinoma. His participation in multi-institutional genomic projects has led to groundbreaking findings in INPP4A-related neurodevelopmental disorders and biallelic mutations in ZBTB11 and MED27 genes. Using bioinformatics and translational genetics approaches, he aims to bridge the gap between molecular insights and clinical applications. He also explores the genetic basis of recurrent implantation failure and precision medicine in oncology. His collaborative work with international consortia highlights his commitment to global research excellence in human genetics, positioning him as a significant contributor to personalized medicine and molecular diagnostics.

✅ Conclusion

Dr. Alihossein Saberi is a leading molecular geneticist whose work spans academia, research, and administration, with a legacy of advancing genetic medicine education and research in Iran through decades of dedicated service, innovation, and collaboration.

Publications

  • Gold nanoparticles in combination with megavoltage radiation energy increased radiosensitization and apoptosis in colon cancer HT-29 cells

    International Journal of Radiation Biology
    2017 | Journal article
    DOI: 10.1080/09553002.2017.1242816

    EID:

    2-s2.0-84994131604

    CONTRIBUTORS: Saberi, A.; Shahbazi-Gahrouei, D.; Abbasian, M.; Fesharaki, M.; Baharlouei, A.; Arab-Bafrani, Z.

  • Impact of prolonged fraction delivery time modelling stereotactic body radiation therapy with high dose hypofractionation on the killing of cultured ACHN renal cell carcinoma cell line

    Journal of Biomedical Physics and Engineering
    2017 | Journal article
    DOI: 10.22086/jbpe.v7i3%20Sep.582

    EID:

    2-s2.0-85029830802

    CONTRIBUTORS: Khorramizadeh, M.; Saberi, A.; Tahmasebi-birgani, M.; Shokrani, P.; Amouhedari, A.

  • The first report of a 290-bp deletion in β-globin gene in the south of Iran

    Iranian Biomedical Journal
    2017 | Journal article
    DOI: 10.18869/acadpub.ibj.21.2.126

    EID:

    2-s2.0-85012202227

    CONTRIBUTORS: Hamid, M.; Nejad, L.D.; Shariati, G.; Galehdari, H.; Saberi, A.; Mohammadi-Anaei, M.

Elijah Stommel | Toxicology | Best Researcher Award

Posted on by Cognitive Scientist Awards

Dr. Elijah Stommel | Toxicology | Best Researcher Award

Dr. Elijah W. Stommel is a distinguished neurologist born in Hamilton, Bermuda 🌊, currently serving as Professor of Neurology at the Geisel School of Medicine at Dartmouth 🧠, renowned for his clinical expertise, pioneering ALS research, and dedication to patient-centered care 💡; his prolific academic journey, consulting roles, and leadership in rare disease research reflect decades of unwavering service to neurology 🏥, academia 📚, and public health advocacy 🧬.

Profile

Education 🎓

Dr. Stommel holds an M.D. (1987) and a Ph.D. in Physiology (1984) from Boston University School of Medicine 🎓; he earned a B.A. with High Honors in Music from Bowdoin College 🎵 (1977), pursued advanced coursework at MIT 🏛️, and honed his research skills as a Research Assistant at the Marine Biological Laboratory in Woods Hole 🔬 — blending physiology, neurology, and music to form a truly interdisciplinary academic foundation 📘.

Experience 👨‍🏫

With over three decades in clinical neurology 🧠, Dr. Stommel progressed from Chief Resident at Dartmouth-Hitchcock (1990-91) to Professor of Neurology (2013–present) 👨‍🏫; he has served as Staff Neurologist at Dartmouth-Hitchcock Clinic since 1991 🏥, held multiple consultant roles across Vermont and New Hampshire 🗺️, and co-directs the Electromyography Lab ⚡, establishing himself as a trusted educator, clinician, and research mentor in both academic and hospital environments 🌟.

Awards & Recognitions 🏅

Dr. Stommel’s commitment to humanism and excellence in neurology earned him a nomination for the prestigious Tow Humanism in Medicine Award 🏆 (2011); he is a Fellow of the American Academy of Neurology 🎖️ and holds long-standing certifications in Electrodiagnostic Medicine and Neurology 🧠, complemented by leadership roles on numerous committees advancing research ethics, clinical trials, and medical education 📋💡.

Research Interests 🔬

Dr. Stommel’s research revolves around neurodegenerative diseases, especially ALS 🧬, exploring environmental toxins 🌿, nanotechnology 🧪, and biomarkers 🔍 to advance diagnostics and therapeutics; as an active reviewer and editor for journals like Nature Nanotechnology, Frontiers in Neurology, and Molecular Neurobiology 🧠, he continually shapes scientific discourse while his collaborative work with global ALS consortia helps identify novel causal pathways and treatment avenues 🌍💡.

Publications